However, we predicted that Ets1 and Ets2 are the potential binding proteins of the Ets site based on their overexpression in breast carcinomas like MCF-7 used in this study [44], [45] and their regulation by PMA through PKC pathway activation [30], [46]. The gene discussed is ETS2; the disease is breast carcinoma.